ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
Shifting the Balance of Therapeutic Radiation in Adolescent and Young Adult Hodgkin Lymphoma.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over recent decades, the use of radiotherapy (RT) in classic Hodgkin lymphoma has shifted toward more conservative, individualized application. In this issue of Cancer Epidemiology, Biomarkers & Prevention, Corrigan and colleagues report on real-world RT utilization trends in adolescent and young adult (AYA) patients in the National Cancer Database who were treated for classic Hodgkin lymphoma from 2004 to 2020 in the United States. The findings parallel broader trends seen in pediatric and adult classic Hodgkin lymphoma toward a lower proportion of patients receiving RT and a reduction in the anatomic regions targeted with RT. Additionally, Corrigan and colleagues identified several demographic factors that were associated with RT receipt, at least some of which may reflect systemic disparities in healthcare delivery. As management strategies in AYA classic Hodgkin lymphoma continue to evolve, ongoing study using large databases will be critical to assess the adoption of evidence-based, equitable practices that maximize disease control and minimize deleterious late effects. The AYA population warrants special attention given their unique characteristics that may affect treatment strategies and patterns of care. See related article by Corrigan et al., p. 1483.
Indexed as
Identifiers
40891185What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.